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Abstract 
Purpose: To investigate the inhibitory effect of S. alata leaf extracts on α-amylase and α-glucosidase, 
and its potential for reducing postprandial blood glucose level of rats.  
Methods: The α-amylase and α-glucosidase inhibitory potentials of acetone, ethylacetate and hexane 
extracts of S. alata were investigated by reacting different concentrations (0.63 – 10.0 mg/mL) of the 
extracts with the enzymes and substrates while the mode(s) of inhibition of both enzymes were 
determined using the Lineweaver-Burk plot. The effect of oral administration of the hexane extract (with 
lowest IC50 for α-glucosidase) of the plant in sucrose-induced hyperglycemic rats was also determined 
by evaluating fasting blood glucose levels. 
Results: The acetone extract of S. alata displayed the highest inhibitory activity against α-amylase (IC50 
= 6.41 mg/mL) while hexane extract exhibited highest inhibitory effect on α-glucosidase (IC50 = 0.85 
mg/mL). Both acetone and hexane extracts inhibited α-amylase and α-glucosidase in a competitive and 
uncompetitive manner respectively. The hexane extract of S. alata also caused significant reduction (p < 
0.05) in the postprandial blood glucose level of sucrose-loaded rats within two hours.  
Conclusions: It can be suggested that one of the mechanisms of anti-diabetic action of S. alata leaf is 
the inhibition of intestinal α-glucosidase.  
 
Keywords: Senna alata, Diabetes, Postprandial hyperglycemia, Phytochemicals, α-glucosidase, α-
amylase 
 
Tropical Journal  of Pharmaceutical Research is indexed by Science Citation Index (SciSearch), Scopus, 
International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African 
Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals 




Senna alata (Cassia alata) Linn. Roxb 
(Leguminosae), known as Ringworm plant, 
winged senna, craw-craw plant or king of the 
forest, is of great importance in traditional 
medical practice in many developing countries 
[1]. In Nigeria, it is called ‘Asunwon oyinbo’ and 
‘Nelkhi’ in the Western and Eastern regions of 
the country respectively. This plant is indigenous 
to several regions of the world such as Africa and 
South America. It is an erect, tropical, annual 
herb of 0.15 m high with leathery, compound 
yellowish-green leaves [2]. It thrives in sunny and 
moist areas and produces a characteristic 
offensive smell.  
 
Ethnopharmacological studies have shown that 
the leaves of the plant (S. alata) have been used 
in the treatment of digestion-related ailments 
such as constipation, abdominal pain and liver 
diseases [3]. It has also enjoyed wide usage in 
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the management of dermatologic diseases like 
dermatitis, skin rash, athlete’s foot, eczema and 
mycosis [4]. The whole plant is used in Brazil, 
Guatemala and Guinea in the treatment of 
malaria, flu and other infectious diseases [3]. 
Studies have also reported the antibacterial, 
antifungal and antiviral properties of S. alata leaf 
[1,6] as well as its laxative [3] and abortifacient 
properties in wistar rats [2]. Of particular interest 
is its use in the management of sugar-related 
disorders such as diabetes mellitus and 
hyperglycaemia [5-7]. 
 
Although S. alata has been validated 
scientifically to possess anti-diabetic property 
[6,7], there is no information on the possible 
mechanism by which this plant elicits its 
hypoglycemic effect. Therefore, the aim of this 
study was to determine the effect of leaf extracts 
of S. alata on α-amylase and α-glucosidase as 
well as its mode of inhibition of these enzymes, 







The leaves of Senna alata were obtained from 
Igando Area of Lagos in Nigeria in May 2013. 
The plant was identified and authenticated by the 
taxonomist Dr AB Kadiri of the Department of 
Botany, University of Lagos, Nigeria and voucher 
specimen (LUH 5603) was deposited in the 
University herbarium. The leaves were dried at 





Male wistar rats were obtained from the Animal 
House of the University of the Free State, South 
Africa. They were housed in plastic cages under 
a 12 h light/dark cycle at 20 – 25 °C and had free 
access to standard rat chow and tap water ad 
libitum. Ethical approval for the study was 
obtained from the Interfaculty Ethics Committee 
of the University of the Free State, South Africa 
with approval number NR 02/2013 and all 
experiments were performed according to the 
Guide for the Care and Use of Laboratory 
Animals [9].  
 
Chemicals and reagents  
 
Porcine pancreatic α-amylase, rat intestinal α-
glucosidase and para nitrophenyl-
glucopyranoside (pNPG) were products of 
Sigma-Adrich Co (St Louis, USA) while soluble 
starch (extra pure) was obtained from JT Baker 
Inc. (Phillipsburg, USA). Other chemicals and 
reagents were of analytical grade and water used 
was glass-distilled. 
 
Preparation of plant extracts  
 
The powdered leaves were divided into three 
portions of 20 g each and these were extracted 
with acetone, ethylacetate or hexane. They were 
all left to steep in covered Erlenmeyer flask for 
24 h and the resulting infusions were decanted, 
filtered with Whatman 150 mm filter paper and 
evaporated to dryness in a rotary evaporator 
(Cole Parmer SB 1100, Shangai, China).  
 
α-Amylase inhibitory assay  
 
This assay was carried out using a modified 
procedure of McCue and Shetty [10]. The extract 
(250 μL, 0.63 – 10.0 mg/mL) was placed in a test 
tube and 250 μL of 0.02 M sodium phosphate 
buffer (pH 6.9) containing α-amylase solution 
(0.5 mg/mL) was added. This solution was pre-
incubated at 25 °C for 10 min, after which 250 μL 
of 1 % starch solution in 0.02 M sodium 
phosphate buffer (pH 6.9) was added at timed 
intervals and then incubated at 25 °C for 10 min. 
The reaction was terminated by adding 500 μL of 
dinitrosalicylic acid (DNS) reagent. The tubes 
were then incubated in boiling water for 5 min 
and cooled to room temperature and the reaction 
mixture was diluted with 5 mL distilled water. 
Absorbance then was measured at 540 nm in a 
spectrophotometer (Spectrumlab S23A, Globe 
Medical England). Distilled water and acarbose 
were used as control and standard respectively. 
The α-amylase inhibitory activity was calculated 
as in Eq 1. 
 
Inhibition (%) = {(Ac-Ae)/Ac}100 ………….. (1) 
 
where Ac and Ae are the absorbance value of 
the control and extract respectively. 
 
Concentrations of extracts resulting in 50 % 
inhibition of enzyme activity (IC50) were 
determined graphically using Microsoft Excel 
2007. 
 
Mode of α-amylase inhibition  
 
The mode of inhibition of α-amylase by the leaf 
extract was conducted using the most potent 
extract according to the modified method 
described by Ali et al [11]. Briefly, 250 μL of the 
extract (5 mg/mL) was pre-incubated with 250 μL 
of α-amylase solution (0.5 mg/mL) for 10 min at 
25 °C in one set of tubes. In another set of tubes, 
α-amylase was pre-incubated with 250 μL of 0.02 
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M sodium phosphate buffer (pH 6.9). Starch 
solutions (250 μL) at increasing concentrations 
(0.3–5.0 mg/mL) were added to both sets of 
reaction mixtures to start the reaction. Each 
mixture was then incubated for 10 min at 25 °C, 
and then boiled for 5 min in a water bath (TW20, 
Julabo GmbH, Germany) after addition of 500 μL 
of DNS to stop the reaction. The amount of 
reducing sugars released was determined 
colorimetrically using a maltose standard curve 
and converted to reaction velocities (mM/min). A 
double reciprocal plot (Lineweaver-Burk) (1/v 
against 1/[S]) where v is reaction velocity and [S] 
is substrate concentration was plotted to 
determine the mode of inhibition.  
 
α-Glucosidase inhibitory assay  
 
The effect of the plant extracts on α-glucosidase 
activity was determined according to the method 
described by Kim et al [12]. The substrate 
solution (3.0 mM), p-nitropheynyl 
glucopyranoside (pNPG) was prepared in 20 mM 
phosphate buffer, pH 6.9. 100 μL of α-
glucosidase (E.C. 3.2.1.20) (0.5 mg/mL) was pre-
incubated with 50 μL of the different 
concentrations of the extracts for 10 min. Then 
50 μL of 3.0 mM pNPG dissolved in 20 mM 
phosphate buffer (pH 6.9) was added to start the 
reaction. The reaction mixture was incubated at 
37 °C for 20 min and stopped by adding 2 mL of 
0.1 M Na2CO3 and the α-glucosidase activity was 
determined by measuring the yellow coloured 
para-nitrophenol released from pNPG at 405 nm 
using spectrophotometer (Spectrumlab S23A, 
Globe Medical England). Distilled water and 
acarbose were used as control and standard 
respectively. Percentage inhibition was 
calculated as in Eq 2. 
 
Inhibition (%) = {(Ac-Ae)/Ac}100 …………. (2) 
 
where Ac and Ae are the absorbances of the 
control and extract respectively. 
 
Concentrations of extracts resulting in 50 % 
inhibition of enzyme activity (IC50) were 
determined graphically using Microsoft Excel. 
 
Mode of α-glucosidase inhibition 
 
The mode of inhibition of α-glucosidase by the 
extracts was determined using the extract with 
the lowest IC50 according to the modified method 
described by Ali et al [11]. Briefly, 50 μL of the 5 
mg/mL extract was pre-incubated with 100 μL of 
α-glucosidase solution (0.5 mg/mL) for 10 min at 
25 °C in one set of tubes. In another set of tubes, 
α-glucosidase was pre-incubated with 50 μL of 
phosphate buffer (pH 6.9). At increasing 
concentrations (0.63 – 2.0 mg/mL), 50 μL of 
pNPG was added to both sets of reaction 
mixtures to start the reaction. The mixture was 
incubated for 10 min at 25 °C and 500 μL of 
Na2CO3 was added to stop the reaction and 
absorbance was read at 405 nm using 
spectrophotometer (Spectrumlab S23A, Globe 
Medical England). The amount of para-
nitrophenol released was determined 
colorimetrically using a para-nitrophenol 
calibration curve and converted to reaction 
velocities. A double reciprocal (Lineweaver-Burk) 
plot (1/v against 1/[S]) where v is reaction 
velocity and [S] is substrate concentration was 




Ten normal rats were divided into two groups of 
five rats (n = 5) each: Group A was designated 
as the control rats while Group B was the 
hexane-extract treated rats. After an overnight 
fast (18 h), groups B rats were administered 
hexane extract of S. alata leaf (250 mg/kg body 
weight) orally by means of an orogastric tube 
while the rats in group A received distilled water 
(vehicle). Both groups were orally administered 3 
g/kg body weight of sucrose solution 30 min after 
the administration of the extract.  Postprandial 
blood glucose levels were then measured before 
(0 min) and at 30, 60, 90 and 120 min after oral 
administration of sucrose using Glucometer 4 
Ames (Bayer Diagnostics, Germany). The 
postprandial blood glucose levels were plotted 




Statistical analysis was performed using 
GraphPad Prism 5 statistical package (GraphPad 
Software, USA). The data were analysed by one 
way analysis of variance (ANOVA) followed by 
Bonferroni test. All results were expressed as 




Figure 1(a) shows the percentage inhibition of α-
amylase activity by different extracts of S. alata. 
At all concentrations tested, the values obtained 
for the three extracts were significantly different 
(p < 0.05) from one another except at 10 mg/mL 
where the values for ethylacetate and hexane 
extract were similar. Acetone extract exhibited 
the highest percentage inhibition of the enzyme 
when compared to other extracts. The IC50 
values generated from the percentage inhibition 
reveals that of all the extracts, acetone extract of 
S. alata has the lowest IC50 value (6.41 mg/mL) 
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but was higher than that of acarbose (5.19 
mg/mL) (Table 1). Kinetic analysis of the α-
amylase inhibition by the acetone extract of S. 
alata leaf using Lineweaver-Burk plot shows that 
it displayed a competitive mode of inhibition 
(Figure 1b). 
 
The percentage inhibition of α-glucosidase 
activity by acetone, ethylacetate and hexane 
extracts of S. alata are presented in Figure 2(a). 
At lower concentrations (0.63 - 2.5 mg/mL), the 
values for hexane extract were significantly 
higher (p < 0.05) than the values for other 
extracts. There were significant differences (p < 
0.05) among all the extracts at 5 mg/mL but at 
the highest concentration (10 mg/mL), the values 
obtained for all the extracts were not significantly 
different from one another. The IC50 values 
generated from the percentage inhibition of the 
extracts reveals that hexane extract has the 
lowest value (0.85 mg/mL) compared to other 
extracts and acarbose (Table 1). Kinetic analysis 
of the α-glucosidase inhibition by the hexane 
extract of S. alata leaf using Lineweaver-Burk 
plot shows that it displayed an uncompetitive 
mode of inhibition (Figure 2b). 
















































Figure 1: Inhibitory potency of S. alata leaf extracts against α-amylase activity (a). Mode of inhibition of α-
amylase by acetone extract of Senna alata (b). Values are expressed as mean ± SEM of triplicate 
determinations. Means not sharing a common letter at the same concentration are significantly different (p < 
0.05) 
 
Table 1: IC50 values for the inhibition of α-amylase and α-glucosidase by different extracts of S. alata leaf and 
acarbose 
 
Extracts IC50 (mg/mL) 
 α-Amylase α-Glucosidase 
Acarbose 5.19 ± 0.15a 1.26 ± 0.02a 
Acetone 6.41 ± 0.12a 4.92 ± 0.10b 
Ethylacetate 10.03 ± 0.31b 4.15 ± 0.07b 
Hexane 12.05 ± 0.38b 0.85 ± 0.02a 
The values are expressed as means ± SEM of triplicate determinations. Means down vertical column not sharing 
common letter are significantly different (ܲ < 0.05). Acarbose is the standard α-amylase and α-glucosidase 
inhibitor 















































Figure 2: Inhibitory potency of S. alata leaf extracts against α-glucosidase activity (a), Mode of inhibition of α-
glucosidase by hexane extract of Senna alata (b). Values are expressed as means ± SEM of triplicate 
determinations. Means not sharing a common letter at the same concentration are significantly different (p < 
0.05) 
Kazeem et al 
Trop J Pharm Res, October 2015; 14(10): 1847  
 
The effect of oral administration of the hexane 
extract of S. alata on sucrose-induced 
hyperglycemia is shown in Figure 3. The result 
shows that the rise in postprandial blood glucose 
level of the control and extract-treated rats were 
similar at the initial period after the administration 
of extract, until at 60 min when the extract 
significantly reduced (p < 0.05) the glucose level. 
This trend of reduction in the extract-treated 
hyperglycaemic animals continued but not 
significant by the end of the experiment. This is 
also corroborated by the significant difference 
between the area under curve (AUC) of the 
control and that of the hexane extract-treated 




Diabetes mellitus is a metabolic disorder 
characterized by hyperglycemia resulting from 
defects in insulin secretion, insulin action or both 
[13]. It affects the metabolism of carbohydrates, 
fats and proteins in the body, leading to several 
complications such as nephropathy, neuropathy 
and retinopathy [14]. According to the 
International Diabetes Federation, the number of 
people living with diabetes in 2013 was  382 
million worldwide and is projected to rise to 592 
million by 2035 [15]. 
 
The management of hyperglycemia is the 
hallmark of treatment in diabetes. One of the 
therapeutic approaches for decreasing 
postprandial hyperglycemia is to retard the 
digestion and absorption of carbohydrates. This 
can be achieved by the inhibition of carbohydrate 
hydrolyzing enzymes, α-amylase and α-
glucosidase, in the digestive tract [16]. Though 
synthetic α-glucosidase inhibitors such as 
acarbose and voglibose are presently in use, 
their use is bedevilled by undesirable side effects 
such as nausea, diarrhoea and liver failure [17]. 
In this study, the low percentage inhibition of α-
amylase by the extracts of Senna alata is a 
pointer to the fact that the plant is a mild inhibitor 
of the enzyme. This is desirable of antidiabetic 
medicinal plants in order to prevent some of the 
side effects produced by synthetic drugs [18]. 
The characteristic competitive inhibition of α-
amylase exhibited by the acetone extract of S. 
alata suggests that the active component in the 
extract is structurally similar to the substrate. 
This suggests that the extract binds reversibly to 
the active site of the enzyme and occupies it in a 
mutually exclusive manner with the substrate 
[19]. 
 




















Figure 3: Effect of administration of hexane extract of 
S. alata on blood glucose level of sucrose-loaded 
normal rats. * Values are significantly lower than the 
control. 
 
Table 2: Pharmacokinetic parameters of control and S. alata treated rats after sucrose ingestion 
 
PK Parameters Groups 
 Control Extract 
Cmax (mg/dL) 140.00 ± 2.50 141.30 ± 3.10 
Tmax (min) 30.00 ± 0.00 30.00 ± 0.00 
AUC (mg/dL.min) 13825.50 ± 20.10 11530.10 ± 16.70* 
The values are expressed as means ± SEM of triplicate determinations. *Mean values are significantly different 
from the control. (Cmax is the maximum blood glucose level of the rats, Tmax is the time at which the maximum 
blood glucose level was attained and AUC is the area under the curve) 
 
The strong inhibition of α-glucosidase by hexane 
extract of S. alata as depicted by the lowest IC50 
(0.85 mg/mL) suggests that it contains potent α-
glucosidase inhibitor, indicating a potential role 
as an antidiabetic natural source. This is 
because any plant which is a strong inhibitor of 
α-glucosidase could serve as effective therapy 
for postprandial hyperglycemia with minimal side 
effects [20]. Lineweaver-Burk plot showed that 
the hexane extract of this plant inhibited α-
glucosidase in an uncompetitive manner. This 
suggests that the inhibitor has no structural 
similarity with the substrate and the inhibitor 
binds exclusively to the enzyme-substrate 
complex yielding an inactive enzyme-substrate-
inhibitor complex [21].  
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In order to confirm the antihyperglycemic effect 
of the hexane extract of S. alata in-vivo, the 
effect of the oral administration of hexane extract 
of S. alata on postprandial hyperglycemia was 
tested. The reduction in the blood glucose level 
of the S. alata extract-treated rats compared to 
the control animals suggest that the hexane 
extract of the plant slowed down the digestion 




Findings from this study show that of all the S. 
alata extracts tested, acetone and hexane extract 
provided the most effective inhibition of α-
amylase and α-glucosidase, respectively, and 
that their mode of inhibiting both enzymes is 
competitive and uncompetitive inhibition, 
respectively. The hexane extract also reduces 
sucrose-induced postprandial hyperglycemia in 
rats. Therefore, it can be concluded that S. alata 
leaf extracts inhibit α-amylase as well as α-
glucosidase and reduced postprandial 
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